Literature DB >> 28688614

Re: Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, et al. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men with Metastatic Castration-resistant Prostate Cancer Treated with First- and Second-line Abiraterone and Enzalutamide. J Clin Oncol 2017;35:2149-56: AR-V7 Testing: What's in it for the Patient?

Julie Steinestel1, Christof Bernemann2, Andres J Schrader2, Jochen K Lennerz3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28688614     DOI： 10.1016/j.eururo.2017.06.031

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

1.  Considerations for AR-V7 testing in clinical routine practice.

Authors:  Christof Bernemann; Laura-Maria Krabbe; Andres Jan Schrader
Journal:  Ann Transl Med       Date:  2019-12

2.  [AR-V7 as a predictive biomarker for prostate cancer-more than just prophecy].

Authors:  C Bernemann; L-M Krabbe
Journal:  Urologe A       Date:  2020-01       Impact factor: 0.639

3.  TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.

Authors:  Bram De Laere; Steffi Oeyen; Markus Mayrhofer; Tom Whitington; Pieter-Jan van Dam; Peter Van Oyen; Christophe Ghysel; Jozef Ampe; Piet Ost; Wim Demey; Lucien Hoekx; Dirk Schrijvers; Barbara Brouwers; Willem Lybaert; Els G Everaert; Daan De Maeseneer; Michiel Strijbos; Alain Bols; Karen Fransis; Nick Beije; Inge E de Kruijff; Valerie van Dam; Anja Brouwer; Dirk Goossens; Lien Heyrman; Gert G Van den Eynden; Annemie Rutten; Jurgen Del Favero; Mattias Rantalainen; Prabhakar Rajan; Stefan Sleijfer; Anders Ullén; Jeffrey Yachnin; Henrik Grönberg; Steven J Van Laere; Johan Lindberg; Luc Y Dirix
Journal:  Clin Cancer Res       Date:  2018-09-12       Impact factor: 12.531

4.  Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.

Authors:  Markus Mayrhofer; Bram De Laere; Tom Whitington; Peter Van Oyen; Christophe Ghysel; Jozef Ampe; Piet Ost; Wim Demey; Lucien Hoekx; Dirk Schrijvers; Barbara Brouwers; Willem Lybaert; Els Everaert; Daan De Maeseneer; Michiel Strijbos; Alain Bols; Karen Fransis; Steffi Oeyen; Pieter-Jan van Dam; Gert Van den Eynden; Annemie Rutten; Markus Aly; Tobias Nordström; Steven Van Laere; Mattias Rantalainen; Prabhakar Rajan; Lars Egevad; Anders Ullén; Jeffrey Yachnin; Luc Dirix; Henrik Grönberg; Johan Lindberg
Journal:  Genome Med       Date:  2018-11-21       Impact factor: 11.117
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.